Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 11%
Sell 11%
Strong Sell 0%

Bulls say

Addus HomeCare Corp has demonstrated strong organic revenue growth in its Personal Care segment, reporting increases of 12.3% year-over-year in 2023, 7.7% in 2024, and 7.4% year-to-date in 2025, reflecting robust demand for non-medical in-home care services. Additionally, the recent 2.6% Medicare Hospice rate increase, effective October 1, 2025, is expected to enhance revenue for the Hospice segment, which is anticipated to grow by 5% to 7% as it stabilizes. The potential for growth is further supported by expected M&A activity and operational improvements in the Hospice division, which could provide additional revenue opportunities in the near term.

Bears say

Addus HomeCare Corp is facing a negative outlook primarily due to significant same-store declines in 2025 year-to-date results, attributed to ongoing impacts from Medicaid redeterminations that have created administrative bottlenecks for patient onboarding and increased discharge rates. Approximately 97% of the company’s segment revenues are reliant on Medicaid, making it vulnerable to uncertainties surrounding future funding after the enactment of the One Big Beautiful Bill Act (OBBBA). Furthermore, despite maintaining a favorable long-term demand backdrop and steady fundamental execution, the company's equity valuation has lagged behind the broader post-acute sector, indicating a disconnect between market performance and its financial fundamentals.

Addus HomeCare (ADUS) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 9 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.